AWM
XERS icon

AE Wealth Management’s Xeris Biopharma Holdings XERS Stock Holding History

AE Wealth Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-79,787
Closed -$123K – 1893
2022
Q2 		$123K Buy
79,787
+9,763
+14% +$20.6K ﹤0.01% 1630
2022
Q1 		$179K Buy
70,024
+10,358
+17% +$25.3K ﹤0.01% 1586
2021
Q4 		$175K Buy
59,666
+13,588
+29% +$29.4K ﹤0.01% 1611
2021
Q3 		$113K Buy
46,078
+5,108
+12% +$14.8K ﹤0.01% 1549
2021
Q2 		$167K Buy
+40,970
New +$156K ﹤0.01% 1514
2020
Q4 		– Sell
-11,140
Closed -$66K – 1444
2020
Q3 		$66K Buy
+11,140
New +$44.5K ﹤0.01% 1227

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AE Wealth Management's XERS Position: Q3 2022 in Review

AE Wealth Management sold out of Xeris Biopharma Holdings (XERS) in Q3 2022, closing a stake of 79,787 shares — an estimated $123K sold.

AE Wealth Management first reported a position in XERS in Q3 2020 and held it in 6 quarters. The position peaked at $179K in Q1 2022. 101 funds tracked by Wall St. Rank hold XERS as of Q3 2022.

  • AE Wealth Management reported no remaining Xeris Biopharma Holdings position as of Q3 2022 after selling out during the quarter.
  • AE Wealth Management sold 79,787 Xeris Biopharma Holdings shares in Q3 2022, an estimated $123K.
  • AE Wealth Management first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 6 quarters.
  • AE Wealth Management's Xeris Biopharma Holdings position peaked at $179K in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2022.

Based on AE Wealth Management's 13F filing for Q3 2022, filed 25 Oct 2022.